<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7344049\results\search\drug\results.xml">
  <result pre="Antiviral agents Status Target pathogens RefS. SARS-CoV-2; MERS-CoV Spike glycoprotein" exact="Nafamostat" post="Approved Anticoagulant therapy in Asian countries [99, 100] SARS-CoV-2;"/>
  <result pre="1b), chronic granulomatous disease (IFN-Î³) SARS-CoV-2; SARS-CoV; MERS-CoV Endosomal acidification" exact="Chloroquine" post="Approved Malaria and certain amoeba infections [99, 104â€&quot;106] Open-label"/>
  <result pre="109] Randomized trial SARS-CoV-2 SARS-CoV; SARS-CoV-2; RSV; HCV MERS-CoV RdRp" exact="Ribavirin" post="Approved HCV and RSV [99] Randomized trial SARS SARS-CoV-2"/>
  <result pre="HCV and RSV [99] Randomized trial SARS SARS-CoV-2 SARS-CoV-2 RdRp" exact="Penciclovir" post="Approved HSV [99] SARS-CoV-2; MERS-CoV; SARS-CoV Remdesivir (GS-5734) Phase"/>
  <result pre="host protein for influenza A virus and is inhibited by" exact="paroxetine" post="acting as virion un-coating can reduce viral load in"/>
  <result pre="if used with or without modification against COVID-19 after investigation." exact="Mesalazine" post="and celecoxib are COX inhibitors having wide-ranging clinical applications"/>
  <result pre="with or without modification against COVID-19 after investigation. Mesalazine and" exact="celecoxib" post="are COX inhibitors having wide-ranging clinical applications for having"/>
  <result pre="because of rapid free radicals release, use of antioxidants like" exact="vitamin C" post="can play a role in COVID-19 management [83]. A"/>
  <result pre="pro-inflammatory cytokine expression in some viruses. Statin in combination with" exact="caffeine" post="is more effective in viral replication inhibition and alleviation"/>
  <result pre="alleviation of lung injury and has a similar activity like" exact="ribavirin" post="and oseltamivir [85]. Since we have no report found"/>
  <result pre="pneumonia: a randomized controlled trialCrit Care Med2019479e735e74331162191 33.LiQLiZYZhangJGuoWNXuXMSunFXet al.Xiyanping Plus" exact="Azithromycin" post="Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: a"/>
  <result pre="immune regulationCurrent opinion in virology201616314026812607 43.CookLELockeMCYoungARMonteKHedbergMLShimakRMet al.Distinct roles of interferon" exact="alpha" post="and beta in controlling chikungunya virus replication and modulating"/>
  <result pre="Yanagisawa A, Levy T, Saul A. early large dose intravenous" exact="vitamin C" post="is the treatment of choice for 2019-nCov pneumonia. 84.LiuYYangYZhangCHuangFWangFYuanJet"/>
  <result pre="Yang X, Liu J, Xu M, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="in JapanJ Gastroenterol Hepatol201631118018926110395 101.FalzaranoDDe WitERasmussenALFeldmannFOkumuraAScottDPet al.Treatment with interferon-Î±2b and" exact="ribavirin" post="improves outcome in MERS-CoVâ€&quot;infected rhesus macaquesNat Med201319101313131724013700 102.ChanJFChanK-HKaoRYToKKZhengB-JLiCPet al.Broad-spectrum"/>
  <result pre="respiratory syndrome coronavirusJ Infect201367660661624096239 103.KimUJWonE-JKeeS-JJungS-IJangH-CCase report combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-Î± for Middle East respiratory syndromeAntiviral Ther201621455459 104.de"/>
 </snippets>
</snippetsTree>
